FAQs Patent Questions

Question:How long does an applicant holder have to submit patent information?

Answer:
Patent information is required to be submitted with all new drug applications at the time of submission of the NDA. If appropriate, the patent information is published at the time of approval of the NDA. For patents issued after approval of the NDA, the applicant holder has 30 days in which to file the patent to have it considered as a timely filed patent. Patents may still be submitted beyond the 30 day timeframe but the patent is not considered a timely filed patent.

Question:Final Patent rejections may be appealed at the U.S patent and Trademark office.

Answer:
If the examiner persists in the rejection of any of the claims in an application, or if the rejection has been made final, the applicant may appeal to the Board of Patent Appeals and Interferences in the United States Patent and Trademark Office.

Question:The Patent Cooperation Treaty facilitates the filing of applications for patents, it is presently adhered to by over 124 countries

Answer:
Another treaty, known as the Patent Cooperation Treaty, was negotiated at a diplomatic conference in Washington, D.C., in June of 1970. The treaty came into force on January 24, 1978, and is presently adhered to by over 124 countries, including the United States. The treaty facilitates the filing of applications for patent on the same invention in member countries by providing, among other things, for centralized filing procedures and a standardized application format.

Bookmark:           
Permalink:  http://S-0.ORG/tHStZwQ

Contact our Patent Professionals to ensure you complete the patent filing process correctly or for violation of your patent rights.